Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report

J Oncol Pharm Pract. 2013 Sep;19(3):261-4. doi: 10.1177/1078155212459285. Epub 2012 Nov 7.

Abstract

Ifosfamide is an alkylating agent used to treat different types of malignancies including lymphomas, sarcomas and germinal cell tumors. Symptoms of ifosfamide neurotoxicity can range from mild confusion, dizziness and hallucination to overt encephalopathy. Various treatment options like methylene blue, albumin infusion and rarely hemodialysis have been used to treat ifosfamide neurotoxicity. We hereby report a case of a patient with relapsed diffuse large B cell lymphoma who received methylene blue after experiencing acute renal failure and encephalopathy due to ifosfamide with no improvement. The prompt use of hemodialysis in this case has led to reversal of both renal failure and neurotoxicity.

Keywords: Ifosfamide neurotoxicity and nephrotoxicity; chemotherapy side effects; hemodialysis.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / therapy
  • Aged
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Diseases / chemically induced*
  • Brain Diseases / therapy
  • Humans
  • Ifosfamide / adverse effects*
  • Ifosfamide / therapeutic use
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Male
  • Renal Dialysis / methods

Substances

  • Antineoplastic Agents, Alkylating
  • Ifosfamide